Basic Sciencemoderate evidence
Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability.
Nature cell biology·May 1, 2026·PMID 42032311
Why it mattersIt reveals a mechanistic vulnerability in senescent cells—GPX4-dependent ferroptosis—and identifies a druggable target for senolytic therapy, which could enhance cancer treatment and address age-related pathologies.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled